| Product NDC: | 11509-0020 |
| Proprietary Name: | Cepacol Sore Throat Plus Cough |
| Non Proprietary Name: | benzocaine and dextromethorphan hydrobromide |
| Active Ingredient(s): | 7.5; 5 mg/1; mg/1 & nbsp; benzocaine and dextromethorphan hydrobromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LOZENGE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 11509-0020 |
| Labeler Name: | Combe Incorporated |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20050728 |
| Package NDC: | 11509-0020-1 |
| Package Description: | 2 BLISTER PACK in 1 CARTON (11509-0020-1) > 9 LOZENGE in 1 BLISTER PACK |
| NDC Code | 11509-0020-1 |
| Proprietary Name | Cepacol Sore Throat Plus Cough |
| Package Description | 2 BLISTER PACK in 1 CARTON (11509-0020-1) > 9 LOZENGE in 1 BLISTER PACK |
| Product NDC | 11509-0020 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | benzocaine and dextromethorphan hydrobromide |
| Dosage Form Name | LOZENGE |
| Route Name | ORAL |
| Start Marketing Date | 20050728 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Combe Incorporated |
| Substance Name | BENZOCAINE; DEXTROMETHORPHAN HYDROBROMIDE |
| Strength Number | 7.5; 5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |